Submission of the AIR FACTORY® PMTA

On behalf of My Vape Order, Inc. (MVO), I am pleased to announce that on September 3, 2020, MVO submitted to the U.S. Food and Drug Administration (FDA) a bundled Premarket Tobacco Application (PMTA) for its AIR FACTORY® brand of e-liquid products. The PMTA covers a suite of 72 AIR FACTORY® products, including both freebase and salt nicotine formulations in a variety of nicotine strengths tailored to meet the needs of our AIR FACTORY® consumers. 

The AIR FACTORY® PMTA meets all statutory and regulatory requirements and is supported by robust scientific data—including independently-conducted toxicological risk assessment data for the submitted products—and thorough research establishing the products to be appropriate for the protection of public health and demonstrating the extensive efforts MVO takes to minimize youth exposure to our products. FDA has publicly advised that it has been inundated with applications in advance of the September 9^th deadline.  We are eagerly awaiting FDA’s Acknowledgement letter and look forward to working with FDA through the scientific review process.    

I am also excited to have recently unveiled re-designed packaging for the AIR FACTORY® brand and to have re-launched MVO’s direct-to-consumer website, www.airfactoryeliquid.com.  We will continue to provide updates regarding AIR FACTORY® products and the PMTA submission through the website, and encourage AIR FACTORY® consumers to register for an account for future updates.

Submission of the AIR FACTORY® PMTA marked the culmination of years of planning and hard work for the MVO team and our valued partners. MVO is honored to be a leader in the vape industry and proud to provide consumers of tobacco and nicotine products a quality line of e-liquids that they can continue to trust and enjoy.

We thank you for your support—stay tuned for future updates!

Kyle Godfrey, CEO